Your Patients Can't Find Amcinonide — Here's How to Help

You prescribed Amcinonide because it was the right clinical choice for your patient's condition. But increasingly, patients are coming back reporting that their pharmacy doesn't carry it, can't order it, or has been out of stock for weeks.

Amcinonide — a Group II high-potency topical corticosteroid — is not in a formal FDA shortage. But its limited manufacturer base and the discontinuation of the brand name Cyclocort have created persistent availability gaps at retail pharmacies across the country.

This guide provides practical, actionable steps you and your staff can take to help patients find Amcinonide — and when to consider alternatives.

Current Availability: What You Need to Know

Here's a quick snapshot of Amcinonide availability in 2026:

• Brand status: Cyclocort permanently discontinued (Pfizer, post-Wyeth acquisition)
• Generic manufacturers: Fewer than 3 active producers
• Pharmacy stocking: Inconsistent at CVS, Walgreens, and other major chains; better at independent pharmacies
• Formulations available: 0.1% cream, ointment, and lotion (cream and ointment most commonly stocked)
• FDA shortage status: Not listed
• Retail price: $2,100-$2,400 per 60g tube without insurance; ~$109-$400 with discount coupons

For a complete timeline of how Amcinonide's supply chain evolved, see our provider shortage briefing.

Why Patients Can't Find Amcinonide

Understanding the "why" helps you set appropriate patient expectations:

Supply Side

• Fewer generic manufacturers means any single production issue creates outsized supply gaps
• No brand-name product means no manufacturer-driven demand or supply guarantees
• Low overall production volume compared to blockbuster topical steroids

Pharmacy Side

• Chain pharmacies stock based on prescription volume — low-volume drugs get dropped
• Automated ordering systems may not restock Amcinonide if it hasn't been dispensed recently
• Pharmacy staff may not be aware it's available through secondary wholesalers

Patient Side

• Patients often don't know they can request special orders or try different pharmacies
• High cash prices ($2,000+) deter uninsured patients from pursuing multiple pharmacy contacts
• Frustration leads some patients to abandon the medication entirely

5 Steps Providers Can Take to Help

Step 1: Check Availability Before Prescribing

Use Medfinder for Providers to check which pharmacies in your patient's area currently have Amcinonide in stock. By identifying a pharmacy with inventory before sending the prescription, you dramatically reduce the chance of a failed fill.

This can be done by your MA or front desk staff as part of the prescription workflow — it takes less than a minute.

Step 2: Send to the Right Pharmacy

Once you've identified a pharmacy with stock, send the e-prescription directly there. If the patient's usual pharmacy doesn't have Amcinonide, this small routing change prevents the frustrating cycle of: prescription sent → pharmacy calls to say out of stock → patient calls office → office transfers prescription → repeat.

Step 3: Include an Alternative on the Prescription Note

Consider adding a note to the pharmacist like: "If Amcinonide unavailable, please contact office. Acceptable alternatives include Fluocinonide 0.05% or Betamethasone Dipropionate 0.05%." This empowers the pharmacist to reach a solution faster.

Step 4: Recommend Independent Pharmacies

If chain pharmacies in your area consistently fail to stock Amcinonide, build a relationship with one or two independent pharmacies that can reliably source it. Independent pharmacies often work with specialty wholesalers and can special-order medications more flexibly.

Keep a running list of pharmacies that your patients have successfully used for Amcinonide and share it with your team.

Step 5: Discuss Cost Proactively

Amcinonide's retail price of $2,100-$2,400 per tube can be a shock. During the visit, mention that discount coupons can bring the price down to around $109-$400 and recommend specific services:

• GoodRx (as low as ~$109)
• SingleCare (~$397)
• Patient's insurance plan (check formulary status)

You can direct patients to our guide on saving money on Amcinonide.

When to Consider Alternatives

If Amcinonide is persistently unavailable for a patient, these alternatives offer comparable clinical efficacy:

• Fluocinonide 0.05%: Group II potency, multiple formulations (cream, gel, ointment, solution), widely available, generic as low as $10-$30
• Betamethasone Dipropionate 0.05%: Group II-III, cream/ointment/lotion/spray, widely available, generic often under $20
• Desoximetasone 0.25%: Group II, cream and ointment, another high-potency option
• Mometasone Furoate 0.1%: Group IV (medium-high), once-daily dosing advantage, widely available

For patients who have specifically responded well to Amcinonide, document the clinical rationale for the switch and monitor for treatment response differences.

See our full comparison in the alternatives to Amcinonide guide.

Workflow Tips for Your Practice

Integrate these practices to reduce Amcinonide-related friction in your office:

• Create a "hard-to-find" medication list: Keep a shared document with medications that have known availability issues, along with verified pharmacies and alternatives.
• Bookmark Medfinder: Add medfinder.com/providers to your EHR favorites or browser toolbar for quick access.
• Pre-print patient handouts: Give patients a one-page guide on finding Amcinonide, including the Medfinder link, tips on calling pharmacies, and coupon resources.
• Schedule follow-up: For patients starting Amcinonide, consider a 2-week phone check-in to confirm they were able to fill the prescription and start treatment.
• Document availability issues: If a patient can't access Amcinonide, document the access barrier in their chart. This supports prior authorization appeals and helps track patterns.

Final Thoughts

Amcinonide is clinically effective, but its supply chain limitations require providers to be proactive. By checking availability before prescribing, routing prescriptions to pharmacies with stock, discussing cost openly, and having alternatives ready, you can minimize treatment delays for your patients.

Use Medfinder for Providers to make this process faster and more reliable. Your patients are already frustrated — anything you can do to smooth the path to filling their prescription makes a real difference.